Underlying mechanisms and clinical potential of circRNAs in glioblastoma

Lei Zhang1, Yuan Zhang1, Huijuan Gao1

  • 1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266021, China.

Oncology Research
|July 7, 2023
PubMed

Insights

Circular RNAs (circRNAs) show promise as biomarkers for glioblastoma (GBM) diagnosis. These molecules regulate GBM progression through various mechanisms, predominantly by sponging microRNAs.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Glioblastoma (GBM) is a highly malignant brain tumor with poor prognosis.
  • Diagnosis of GBM is challenging, contributing to high mortality rates.
  • Circular RNAs (circRNAs) are emerging as key players in cancer development.

Purpose of the Study:

  • To review the characteristics and mechanisms of circRNAs.
  • To elucidate the role of circRNAs in glioblastoma pathogenesis.
  • To explore the diagnostic potential of circRNAs for GBM.

Main Methods:

  • Literature review and synthesis of current research on circRNAs and GBM.
  • Analysis of circRNA functions including miRNA and RNA-binding protein sponging, gene transcription modulation, and protein coding.
  • Evaluation of circRNA properties relevant to biomarker development (stability, distribution, specificity).

Main Results:

  • CircRNAs regulate GBM progression via multiple mechanisms, with microRNA sponging being predominant.
  • The stability, broad distribution, and specificity of circRNAs suggest their utility in GBM diagnosis.
  • Understanding circRNA regulatory networks in GBM is crucial for developing novel diagnostic strategies.

Conclusions:

  • CircRNAs are significant regulators in glioblastoma pathogenesis.
  • CircRNAs hold considerable promise as diagnostic biomarkers for GBM.
  • Further research into circRNA mechanisms can advance GBM diagnostics and treatment.